Evidence map›Paper›PMID 33244198›Full record

ArticleWorld journal of gastroenterology2020

P-selectin glycoprotein ligand 1 deficiency prevents development of acute pancreatitis by attenuating leukocyte infiltration.

Xu Zhang, Ming Zhu, Xiao-Liang Jiang, Xing Liu, Xue Liu, Pan Liu, Xian-Xian Wu, Zhi-Wei Yang, Tao Qin

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Frontiers in pharmacology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Circulating monocytes in acute pancreatitis.Frontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xu ZhangAcademy of Medical Sciences, Zhengzhou University, Zhengzhou 450003, Henan Province, China.
Ming ZhuZhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510000, Guangdong Province, China.
Xiao-Liang JiangInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage (PUMC), Beijing 100021, China.
Xing LiuInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage (PUMC), Beijing 100021, China.
Xue LiuInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage (PUMC), Beijing 100021, China.
Pan LiuDepartment of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou 450003, Henan Province, China.
Xian-Xian WuInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage (PUMC), Beijing 100021, China.
Zhi-Wei YangInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical Collage (PUMC), Beijing 100021, China.
Tao QinAcademy of Medical Sciences, Zhengzhou University, Zhengzhou 450003, Henan Province, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNZhengzhou University · CNHenan Provincial People's Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute pancreatitis (AP) is rapid-onset pancreatic inflammation that causes local and systemic inflammatory response syndrome (SIRS) with high morbidity and mortality, but no approved therapies are currently available. P-selectin glycoprotein ligand 1 (PSGL-1) is a transmembrane glycoprotein to initiate inflammatory responses. We hypothesized that PSGL-1 may be involved in the development of AP and would be a new target for the treatment of AP.

aimTo investigate the role and mechanism of PSGL-1 in the development of AP.

methodsThe PSGL-1 expression on leukocytes was detected in peripheral blood of AP patients and volunteers. Pancreatic injury, inflammatory cytokines expression, and inflammatory cell infiltration was measured in AP mouse models induced with PSGL-1 knockout (

resultsThe expression of PSGL-1 on monocytes and neutrophils was significantly increased in AP patients. Compared with

conclusionPSGL-1 deficiency effectively inhibits the development of AP by preventing leukocyte-endothelial cell adhesion

Indexed as

Acute DiseaseAnimalsHumansLeukocytesLeukocytes, MononuclearLigandsMembrane GlycoproteinsMiceMice, Inbred C57BLPancreatitisLigandsMembrane GlycoproteinsP-selectin ligand proteinAcute pancreatitisInflammationInterleukin-6Leukocyte adhesionP-selectin glycoprotein ligand 1

Identifiers

PMID33244198
PMCPMC7656215
OpenAlexW3095202099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.